Integrated Patient Care Systems Market Growth Accelerated by Enhanced Adoption of Telehealth Solutions


 Integrated patient care systems provide convenient access to holistic healthcare for patients by consolidating all medical records, treatment plans and services in a single, digital platform. These systems enable seamless communication between healthcare providers, labs and patients through online appointment scheduling, video consultations, prescription management and billing functions. Their ability to streamline medical processes and enhance care coordination in a cost effective manner has accelerated amidst the COVID-19 pandemic as more patients and providers embraced telehealth solutions.


The global Integrated Patient Care Systems Market is estimated to be valued at US$ 33,450 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rapid adoption of telehealth solutions has emerged as a key driver of growth for the integrated patient care systems market. Lockdowns and social distancing measures during the pandemic restricted in-person visits, prompting healthcare providers to offer virtual consultations using integrated platforms. Their all-in-one functionalities allowed seamless transition to the digital realm, facilitating continuity of care. Telehealth is expected to remain an integral part of the healthcare experience even post-pandemic, with patients appreciating its convenience. This will further stimulate investments in innovative integrated systems integrating robust telemedicine capabilities.

Segment Analysis
The global integrated patient care systems market is dominated by the blood component collection and processing sub segment. This sub segment holds around 55% share of the overall market due to growing demand for blood and blood components for transfusion and treatment of various blood disorders and injuries across the globe. Blood components such as red blood cells, fresh frozen plasma, cryoprecipitate, platelets and others are widely used medical procedures and therapies.

Key Takeaways

The global integrated patient care systems market size was valued at US$ 33,450 Mn in 2024 and is expected to reach over US$ 56,000 Mn by 2030 expanding at a CAGR of 6.8% during the forecast period.
 
Regional analysis: North America accounts for the largest share of over 35% of the global integrated patient care systems market owing to rising cases of lifestyle diseases, increasing road accidents and trauma injuries, growing investments by public and private players towards blood collection and screening infrastructure, and presence of sophisticated healthcare system in the region. Asia Pacific is expected to witness the highest CAGR during the forecast period owing to rising healthcare expenditure, increasing awareness about blood donation, growing geriatric population, and improving healthcare infrastructure in countries such as China and India.

Key players: Key players operating in the integrated patient care systems market are Grifols, S.A., SK Plasma, Fusion Healthcare, Takeda Pharmaceutical Company Limited, LFB, Octapharma AG. Grifols, S.A. is one of the leading players with over 15% share in blood collection equipment and supplies market. The company offers innovative solutions and services for blood component collection, donated plasma collection and blood typing.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more